In addition, according to the FHL3 expression and the follow-up time of 120 GC patients, Kaplan–Meier analysis indicated that higher expression of FHL3 leads to worse prognosis in GC patients (P < 0.001, Figure 2C). The gene discussed is FHL3; the disease is gastric cancer.